EcoDrugPlus

Voltage-Dependent Calcium Channel Gamma-4 Subunit

Ensembl ID : ENSELUG00000006621
Gene Symbol: LOC105013014
3 Cross references
192 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit

Ensembl ID : ENSELUG00000022086
Gene Symbol: LOC105025871
3 Cross references
168 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit

Ensembl ID : ENSELUG00000029838
Gene Symbol: LOC105025870
3 Cross references
181 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-7 Subunit

Ensembl ID : ENSELUG00000022111
Gene Symbol: LOC105025872
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-1

Ensembl ID : ENSELUG00000001792
Gene Symbol: LOC105020378
3 Cross references
230 Possible Orthologues:

Wee1-Like Protein Kinase 1-A

Ensembl ID : ENSELUG00000004431
Gene Symbol: LOC105018641
3 Cross references
206 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSELUG00000019382
Gene Symbol: XDH
3 Cross references
212 Possible Orthologues:

Ensembl ID : ENSELUG00000016364
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSELUG00000024948
Gene Symbol: -
Cross references: -
318 Possible Orthologues:

Ensembl ID : ENSELUG00000019708
Gene Symbol: -
Cross references: -
132 Possible Orthologues:

Ensembl ID : ENSELUG00000016691
Gene Symbol: -
Cross references: -
304 Possible Orthologues:

Ensembl ID : ENSELUG00000015261
Gene Symbol: -
Cross references: -
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).